珠海冠宇(688772.SH):二季度公司筆電類產品出貨量環比及同比均有所增長
格隆匯8月8日丨珠海冠宇(688772.SH)近期在接待機構投資者調研時表示,2023年二季度,公司筆電類產品的出貨量環比及同比均有所增長。2023年上半年度公司歸屬於母公司所有者的淨利潤及歸屬於母公司所有者的扣除非經常性損益的淨利潤同比變動幅度較大,主要系受益於美元兑人民幣匯率上升、原材料市場價格下降、限制性股票激勵計劃確認的股份支付費用減少、持續推進精細化管理提升生產運營效率等多重因素綜合影響所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.